Commentary on “Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.” Developing a blood test for Alzheimer's disease using advanced genomic expression technology-Reference-Cited by-同舟云学术

Commentary on “Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.” Developing a blood test for Alzheimer's disease using advanced genomic expression technology

Published:2010-03 Issue:2 Volume:6 Page:147-149
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Einstein Richard¹

Affiliation:

1. Molecular Diagnostics, Research and DevelopmentExonHit Therapeutics, IncGaithersburgMDUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2010.01.001

Reference19 articles.

1. Interpreting biomarker data in therapeutic trials

2. LeowA.D. YanovskyI. ParikshakN. HuaX. LeeS. TogaA.W. JackC.R.Jr BernsteinM.A. BritsonP.J. GunterJ.L. WardC.P. BorowskiB. ShawL.M. TrojanowskiJ.Q. FleisherA.S. HarveyD. KornakJ. SchuffN. AlexanderG.E. WeinerM.W. ThompsonP.M.;Alzheimer's Disease Neuroimaging Initiative. Alzheimer's disease neuroimaging initiative: a one‐year follow up study using tensor‐based morphometry correlating degenerative rates biomarkers and cognition. Neuroimage. 200915;45:645–655.

3. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

4. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines

5. A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-06-14

2. Deconstructing GSK-3: The Fine Regulation of Its Activity;International Journal of Alzheimer's Disease;2011

3. Current awareness in geriatric psychiatry;International Journal of Geriatric Psychiatry;2010-10-18